These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26013022)

  • 1. Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates.
    Sankineni S; Smedley J; Bernardo M; Brown AM; Johnson L; Muller B; Griffiths GL; Kobayashi H; Rais-Bahrami S; Pinto PA; Wood BJ; Keele B; Choyke PL; Turkbey B
    Acta Radiol; 2016 Nov; 57(11):1396-1401. PubMed ID: 26013022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.
    Turkbey B; Agarwal HK; Shih J; Bernardo M; McKinney YL; Daar D; Griffiths GL; Sankineni S; Johnson L; Grant KB; Weaver J; Rais-Bahrami S; Harisinghani M; Jacobs P; Dahut W; Merino MJ; Pinto PA; Choyke PL
    AJR Am J Roentgenol; 2015 Jul; 205(1):64-9. PubMed ID: 26102381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles.
    Winter A; Kowald T; Paulo TS; Goos P; Engels S; Gerullis H; Schiffmann J; Chavan A; Wawroschek F
    Int J Nanomedicine; 2018; 13():6689-6698. PubMed ID: 30425483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic Sentinel Lymph Node Detection in Prostate Cancer after intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles].
    Winter A; Engels S; Kowald T; Paulo TS; Gerullis H; Chavan A; Wawroschek F
    Aktuelle Urol; 2017 Apr; 48(2):132-139. PubMed ID: 28324908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance sentinel lymph node imaging of the prostate with gadofosveset trisodium-albumin: preliminary results in a canine model.
    Turkbey B; Hoyt RF; Agarwal HK; Bernardo M; Sankineni S; Johnson L; Grant KB; Rais-Bahrami S; Kobayashi H; Wood BJ; Pinto PA; Griffiths GL; Choyke PL
    Acad Radiol; 2015 May; 22(5):646-52. PubMed ID: 25683498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
    Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
    Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging of Sentinel Lymph Nodes Using Intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles in Prostate Cancer Patients: First-in-human Results.
    Winter A; Chavan A; Wawroschek F
    Eur Urol; 2018 May; 73(5):813-814. PubMed ID: 29402548
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
    Ning P; Zucker EJ; Wong P; Vasanawala SS
    Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.
    Turkbey B; Czarniecki M; Shih JH; Harmon SA; Agarwal PK; Apolo AB; Citrin DE; Gulley JL; Harisinghani M; Madan RA; Metwalli AR; Paquette E; Pinto PA; Rais-Bahrami S; Rowe LS; Wood BJ; Jacobs PM; Lindenberg L; Dahut W; Choyke PL
    AJR Am J Roentgenol; 2020 Jan; 214(1):105-113. PubMed ID: 31613660
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR; Bhatti L; Marin D; Nelson RC
    J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a new bolus-injectable nanoparticle for clinical cancer staging.
    Harisinghani M; Ross RW; Guimaraes AR; Weissleder R
    Neoplasia; 2007 Dec; 9(12):1160-5. PubMed ID: 18084623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Ferumoxytol be Used as a Contrast Agent to Differentiate Between Acute and Chronic Inflammatory Kidney Disease?: Feasibility Study in a Rat Model.
    Budjan J; Neudecker S; Schock-Kusch D; Kraenzlin B; Schoenberg SO; Michaely HJ; Attenberger UI
    Invest Radiol; 2016 Feb; 51(2):100-5. PubMed ID: 26352750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node surgery in prostate cancer using magnetic particles.
    Winter A; Engels S; Wawroschek F
    Curr Opin Urol; 2018 Mar; 28(2):184-190. PubMed ID: 29278579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
    Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
    Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.
    Thoeny HC; Triantafyllou M; Birkhaeuser FD; Froehlich JM; Tshering DW; Binser T; Fleischmann A; Vermathen P; Studer UE
    Eur Urol; 2009 Apr; 55(4):761-9. PubMed ID: 19144456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
    Pandharipande PV; Mora JT; Uppot RN; Goehler A; Braschi M; Halpern EF; Gazelle GS; Harisinghani MG
    AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ferumoxytol magnetic resonance imaging on the rhesus macaque maternal-fetal interface†.
    Nguyen SM; Wiepz GJ; Schotzko M; Simmons HA; Mejia A; Ludwig KD; Zhu A; Brunner K; Hernando D; Reeder SB; Wieben O; Johnson K; Shah D; Golos TG
    Biol Reprod; 2020 Feb; 102(2):434-444. PubMed ID: 31511859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
    Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.